Literature DB >> 27500444

MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination-what we learned from microRNA-494.

Margarita González-Vallinas1, Kai Breuhahn1.   

Abstract

Entities:  

Year:  2016        PMID： 27500444      PMCID： PMC4960416          DOI： 10.21037/hbsn.2016.05.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  25 in total

1.  Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

Authors:  Y Liu; X Li; S Zhu; J-g Zhang; M Yang; Q Qin; S-c Deng; B Wang; K Tian; L Liu; Y Niu; C-y Wang; G Zhao
Journal:  Gene Ther       Date:  2015-04-28       Impact factor: 5.250

Review 2.  How epigenetics can explain human metastasis: a new role for microRNAs.

Authors:  Amaia Lujambio; Manel Esteller
Journal:  Cell Cycle       Date:  2009-02-01       Impact factor: 4.534

Review 3.  MicroRNA-mediated interactions between host and hepatitis C virus.

Authors:  Hu Li; Jian-Dong Jiang; Zong-Gen Peng
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.

Authors:  Ernest Nadal; Jinjie Zhong; Jules Lin; Rishindra M Reddy; Nithya Ramnath; Mark B Orringer; Andrew C Chang; David G Beer; Guoan Chen
Journal:  Clin Cancer Res       Date:  2014-05-15       Impact factor: 12.531

5.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

6.  miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.

Authors:  Na Li; Xiaosu Zhao; Lufei Wang; Shi Zhang; Manhua Cui; Jin He
Journal:  Tumour Biol       Date:  2015-12-22

7.  MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.

Authors:  Kuang-Hsiang Chuang; Christa L Whitney-Miller; Chin-Yi Chu; Zhongren Zhou; M Katherine Dokus; Shannon Schmit; Christopher T Barry
Journal:  Hepatology       Date:  2015-05-06       Impact factor: 17.425

8.  Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers.

Authors:  Saurabh V Laddha; Subhashree Nayak; Deepanjan Paul; Rajasekhara Reddy; Charu Sharma; Prerana Jha; Manoj Hariharan; Anurag Agrawal; Shantanu Chowdhury; Chitra Sarkar; Arijit Mukhopadhyay
Journal:  Biol Direct       Date:  2013-04-24       Impact factor: 4.540

Review 9.  Emerging role of microRNAs in lipid metabolism.

Authors:  Zhihong Yang; Tyler Cappello; Li Wang
Journal:  Acta Pharm Sin B       Date:  2015-02-24       Impact factor: 11.413

10.  A genome-wide integrative study of microRNAs in human liver.

Authors:  Eric R Gamazon; Federico Innocenti; Rongrong Wei; Libo Wang; Min Zhang; Snezana Mirkov; Jacqueline Ramírez; R Stephanie Huang; Nancy J Cox; Mark J Ratain; Wanqing Liu
Journal:  BMC Genomics       Date:  2013-06-13       Impact factor: 3.969
View more
  4 in total

Review 1.  Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.

Authors:  Nosheen Masood; Zarrin Basharat; Tabeer Khan; Azra Yasmin
Journal:  Pathol Oncol Res       Date:  2017-01-09       Impact factor: 3.201

Review 2.  Hepatocellular Carcinoma: The Role of MicroRNAs.

Authors:  Sharad Khare; Tripti Khare; Raghu Ramanathan; Jamal A Ibdah
Journal:  Biomolecules       Date:  2022-04-27

3.  Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice.

Authors:  Zhonglin Wu; Yuanyuan Zhang; Tao Song; Qiongtao Song; Ying Zhang; Xuan Zhang; Xue Han; Jianping Zhang; Li Chu
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

Review 4.  Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.

Authors:  Yongbing Sun; Wen Ma; Yuanyuan Yang; Mengxue He; Aimin Li; Lei Bai; Bin Yu; Zhiqiang Yu
Journal:  Asian J Pharm Sci       Date:  2019-06-12       Impact factor: 6.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.